1. Home
  2. IVA vs INVZ Comparison

IVA vs INVZ Comparison

Compare IVA & INVZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVA
  • INVZ
  • Stock Information
  • Founded
  • IVA 2011
  • INVZ 2016
  • Country
  • IVA France
  • INVZ Israel
  • Employees
  • IVA N/A
  • INVZ N/A
  • Industry
  • IVA Biotechnology: Pharmaceutical Preparations
  • INVZ Auto Parts:O.E.M.
  • Sector
  • IVA Health Care
  • INVZ Consumer Discretionary
  • Exchange
  • IVA Nasdaq
  • INVZ Nasdaq
  • Market Cap
  • IVA 117.3M
  • INVZ 114.2M
  • IPO Year
  • IVA 2020
  • INVZ N/A
  • Fundamental
  • Price
  • IVA $2.17
  • INVZ $1.88
  • Analyst Decision
  • IVA Strong Buy
  • INVZ Buy
  • Analyst Count
  • IVA 4
  • INVZ 6
  • Target Price
  • IVA $13.25
  • INVZ $3.81
  • AVG Volume (30 Days)
  • IVA 6.4K
  • INVZ 15.2M
  • Earning Date
  • IVA 09-25-2024
  • INVZ 02-26-2025
  • Dividend Yield
  • IVA N/A
  • INVZ N/A
  • EPS Growth
  • IVA N/A
  • INVZ N/A
  • EPS
  • IVA N/A
  • INVZ N/A
  • Revenue
  • IVA $20,652,523.00
  • INVZ $33,158,000.00
  • Revenue This Year
  • IVA N/A
  • INVZ $18.38
  • Revenue Next Year
  • IVA $361.78
  • INVZ $244.43
  • P/E Ratio
  • IVA N/A
  • INVZ N/A
  • Revenue Growth
  • IVA N/A
  • INVZ 339.99
  • 52 Week Low
  • IVA $1.53
  • INVZ $0.45
  • 52 Week High
  • IVA $4.50
  • INVZ $3.14
  • Technical
  • Relative Strength Index (RSI)
  • IVA 39.56
  • INVZ 60.35
  • Support Level
  • IVA $2.11
  • INVZ $1.60
  • Resistance Level
  • IVA $2.24
  • INVZ $1.75
  • Average True Range (ATR)
  • IVA 0.07
  • INVZ 0.30
  • MACD
  • IVA 0.01
  • INVZ -0.04
  • Stochastic Oscillator
  • IVA 26.58
  • INVZ 29.21

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

About INVZ Innoviz Technologies Ltd. Ordinary shares

Innoviz Technologies Ltd is a provider of solid-state LiDAR and perception solutions that feature technological breakthroughs across core components and bring enhanced vision and superior performance to enable safe autonomous driving at a mass scale. The company provides a complete and comprehensive solution for OEMs and Tier-1 partners that are developing and marketing autonomous driving vehicles to the passenger cars and other relevant markets, such as robotaxis, shuttles, delivery vehicles, buses and trucks, and other industries that require 3-dimensional high resolution sensors. Company's solutions can enable safe autonomy for industries like logistics, drones, robotics, construction and other industrial applications, agriculture, smart city, smart infrastructure, security and mapping.

Share on Social Networks: